The association between cardiovascular disease and breast and gynecologic cancers among black female patients.


Journal

Journal of the National Medical Association
ISSN: 1943-4693
Titre abrégé: J Natl Med Assoc
Pays: United States
ID NLM: 7503090

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 26 01 2023
revised: 01 06 2023
accepted: 17 07 2023
medline: 23 10 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: ppublish

Résumé

Little is known about whether a breast or gynecologic cancer diagnosis increases long-term cardiovascular disease (CVD) risk among Black females. The purpose of this study was to determine whether a breast or gynecologic cancer diagnosis is associated with CVD risk and identify determinants of subsequent CVD risk among Black females with an incident breast or gynecologic cancer diagnosis. Using the Southern Community Cohort Study data from 2002-2016, this study was designed to analyze CVD incidence among Black females without cancer or CVD at enrollment. Cox proportional hazards regression models with or without covariates were used to explore the relationship between a breast or gynecologic cancer diagnosis and CVD risk among women without cancer as well as without CVD at enrollment (N=11,486). In addition, Cox proportional hazards regression models, excluding those who developed CVD before breast and gynecologic cancer diagnosis and those with other types of cancers, were used to assess determinants of CVD risk among breast and gynecologic cancer survivors. Of 11,486 Black females, 531 developed a breast or gynecological cancer (4.6%) over a median follow-up of 140 months (interquartile range: 123-159 months). Compared to women without cancer, women with a breast or gynecological cancers had greater than 20% higher risk of incident CVD during the follow-up period. Without adjusting for covariates, positive association between CVD risk and breast cancer was observed (hazard ratio (HR) = 1.24; 95% confidence interval (CI) = 1.11 - 1.39; p < 0.001); as well as between CVD risk and a gynecological cancer (HR = 1.23; 95% CI = 1.03 - 1.46; p = 0.021). Yet, after adjusting for covariates, CVD risk was only significantly associated with breast cancer (p = 0.001) but not gynecologic cancer. In cancer case-only analyses, CVD risk was significantly increasing with age (p < 0.05). Like study populations of predominantly White females, our results suggest that, adjusting for covariates, Black females possess a higher risk of CVD following a breast cancer diagnosis compared to women who did not develop breast cancer. Our results suggest a need for active CVD surveillance in the cancer survivorship phase.

Identifiants

pubmed: 37558599
pii: S0027-9684(23)00085-8
doi: 10.1016/j.jnma.2023.07.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

466-474

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Karen Patricia Williams (KP)

Martha S. Pitzer Center for Women, Children, and Youth, College of Nursing, The Ohio State University, Columbus, Ohio, United States. Electronic address: williams.5963@osu.edu.

Chyongchiou J Lin (CJ)

Martha S. Pitzer Center for Women, Children, and Youth, College of Nursing, The Ohio State University, Columbus, Ohio, United States.

Ashley S Felix (AS)

Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States.

Daniel Addison (D)

Cardio-Oncology Program, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States.

Vanessa B Sheppard (VB)

Department of Health Behavior and Policy, School of Medicine, V.B. Sheppard and A.L. Sutton, Virginia Commonwealth University, Richmond, VA, United States.

Arnethea L Sutton (AL)

Department of Health Behavior and Policy, School of Medicine, V.B. Sheppard and A.L. Sutton, Virginia Commonwealth University, Richmond, VA, United States.

Michael T Mumma (MT)

Vanderbilt University Medical Center, Nashville, TN, United States.

Wansoo Im (W)

Department of Family and Community Medicine, Meharry Medical College, Nashville, TN, United States.

Paul D Juarez (PD)

Department of Family and Community Medicine, Meharry Medical College, Nashville, TN, United States.

Darryl B Hood (DB)

Division of Environmental Health Sciences, College of Public Health, The Ohio State University, Columbus, Ohio, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH